HAL Allergy Extends GMP Contract Manufacturing Activities

Informations

• Publié par: hal-allergy-group
• Nombre de lectures: 24
• Langue: English

Extrait

HAL Allergy Extends GMP Contract

Manufacturing Activities

PR Newswire

LEIDEN, The Netherlands, July 6, 2012

LEIDEN,

The Netherlands

,

July 6, 2012

/PRNewswire/ --

HAL Allergy B.V. announced that it succeeded in

extending its GMP contract manufacturing activities for

clinical batch supply of both recombinant and viral

products. The Dutch inspectorate granted the permit

extension after inspection of the operational activities

in the BSL2 clean rooms and development laboratory in

June 2012

.

In 2009 HAL Allergy opened its state-of-the-art production facility at the Bio

Science Park in Leiden. In order to offer the competences of its pharmaceutical

specialists to customers in need of reliable GMP services, the business was

expanded into contract manufacturing. During the start up of this new business,

the cooperation with the contract research organization Batavia Bioservices,

for process know how and Yxion for engineering were crucial.

"The fact that the Dutch authorities extended our GMP permit, is a big step

forward in our goal of becoming a key biotech service company. Our team of

specialists offer our clients reliable and effective services. Modern production-

and laboratory facilities and over 50 years experience in vaccine production will

be key asset in partnerships with our customers" says Harry Flore, CEO of HAL

Allergy.

About HAL Allergy

The HAL Allergy Group (http://www.hal-allergy.com) was established in 1959

and is an important European manufacturer of allergy vaccines and

diagnostics. Today HAL Allergy is a modern company with high quality

pharmaceutical, manufacturing and research facilities and many years of GMP

tradition. The Group's products are distributed via subsidiaries in

Germany

,

Spain

,

Italy

,

Poland

,

Austria

and the Benelux as well as a network of distribution

partners around

Europe

. Currently HAL Allergy employs over 280 people

throughout

Europe

with more than 160 situated in

the Netherlands

HQ.